Warberg Asset Management’s TransCode Therapeutics RNAZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,786
| Closed | -$24.8K | – | 198 |
|
|
2025
Q1 | $24.8K | Buy |
+1,786
| New | +$24.8K | ﹤0.01% | 118 |
|
|
2023
Q4 | – | Hold |
0
| – | -$5.03K | – | 242 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 171 |
|
|
2023
Q2 | – | Hold |
0
| – | -$6.77K | – | 245 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 176 |
|